BAYER A.G. (BAYZF)
Clinical trial NCT04489719 updates: 1. completion date: 2029-08-01 → 2030-08-01 2. primary completion date: 2026-08-01 → 2027-08-01
Clinical trial NCT04489719 updates: 1. completion date: 2029-08-01 → 2030-08-01 2. primary completion date: 2026-08-01 → 2027-08-01
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical